Treatment comparisons must be fair

Untrustworthy treatment comparisons are those in which biases, or the play of chance, or both result in misleading estimates of the effects of treatments. Fair treatment comparisons avoid biases and reduce the effects of the play of chance.


JLL Essay
1.3 Why treatment comparisons must be fair

Fair tests of treatments

 

FILTER CLEAR FILTERS

SORT date author


FILTER RECORDS BY


Daniel (6th century BCE)
The Book of Daniel, Chapter 1:1-16.

View

al-Razi (10th century CE)
Shukuk ala Jalinus. [Doubts about Galen]

View

Ibn Hindu (10th-11th century CE; 4th-5th century AH)
Miftah al-tibb wa-minhaj al-tullab [The key to the science of medicine and the students' guide].

View

Ben Cao Tu Jing (11th century)
Atlas of Materia Medica. Song Dynasty (960-1279).

View

Abd al-Latif ibn Yusuf al-Baghdadi (13th century CE, 7th century AH)
The Book of the Two Pieces of Advice by Abd al-Latif, the son of Yusuf, to the General Public (Kitab al-Nasihatain min Abd al-Latif b. Yusuf ila l-nas kaffatan). Bursa: MS Hüseyin Çelebi 823, item number 5; medical section on fol. 62a-78a; philosophical section: fol. 78b-100b.

View

al-Razi (10th century CE; 4th century AH)
Kitab al-Hawi fi al-tibb [The comprehensive book of medicine].

View

Ibn Sīnā (c.1012 CE; c.402 AH)
Kitab al-Qanun fi al-tibb [Avicenna’s The Canon of Medicine].

View

Bacon, Roger (1266)
Opus maius. MS Digby 325, 15th century manuscript. Bodleian Library, Oxford.

View

Petrarca F (14th century)
Letter to Boccaccio. Print: Senilium Liber V Epistola iii in: Annotatio nonnullorum librorum seu epistolarum Francisci Petrarche. Venetiis: Torresanus de Asula (1501). Manuscript: Key passage in the late 14th / early 15th century manuscript Biblioteca Marciana Lat. XI 17 / Francesco Petrarca; fol. 28r, second column, lines 9 – 22. (Facsimile of MS: Petrarca F (2003). Seniles, (eds Stocchi MP, Marcon S). Venice: Marsilio.)

View

Fioravanti L (1573)
Communication addressed to "Illustrissimo e Eccellentissimo Signor Al Protofisico Boldon e al Vicario di Giustizia", 22 xxxx 1573.

View

Bacon F (1645)
Franc Baconis de Verulamio / Summi Angliae Cancellarii /Novum organum scientiarum. Lugd. Bat: apud Adrianum Wiingaerde, et Franciscum Moiardum. Aphorism XLVI (pages 45-46).

View

Starkey G (1657)
Natures explication and Helmont’s vindication…Or A short and sure way to a long and sound life. London: printed by E. Cotes for Thomas Alsop at the two Sugar-loaves over against St. Antholins Church at the lower end of Watling Street.

View

Nettleton T (1722)
Part of a letter from Dr. Nettleton, physician at Halifax, to Dr. Jurin, R. S. Sec concerning the inoculation of the small pox, and the mortality of that distemper in the natural way. Philosophical Transactions of the Royal Society of London (1722-1723) 32:209-212.

View

Massey I (1723)
A short and plain account of inoculation. With some remarks on the main argument made use of to recommend that practice, by Mr. Maitland and others. To which is added, a letter to the learned James Jurin, M.D.R.S. Secr. Col. Reg. Med. Lond. Soc. London: W. Meadows.

View

Clifton F (1732)
The state of physick, ancient and modern, briefly considered: with a plan for the improvement of it. London printed by W Bowyer, for John Nourse without Temple-Bar.

View

Hillary W (1761)
An inquiry into the means of improving medical knowledge. London: Hitch and Hawes.

View

Lind J (1762)
An essay on the most effectual means of preserving the health of seamen, in the Royal Navy. London: D Wilson.

View

Lind J (1763)
Two papers on fevers and infection. London: D Wilson.

View

Watson W (1768)
An account of a series of experiments, instituted with a view of ascertaining the most successful method of inoculating the smallpox. London: J Nourse.

View

Aikin J (1771)
Thoughts on hospitals. London: Joseph Johnson.

View

Lind J (1771)
An essay on diseases incidental to Europeans in hot climates. London: Becket and De Hondt.

View

Gregory J (1772)
Lectures on the duties and qualifications of a physician. London: Strahan and Cadell. (new ed.) Edinburgh: Creech.

View

Sims J (1774)
A discourse on the best methods of prosecuting medical enquiries. London: J Johnson, p78-9, 80, 86-88, 99-101.

View

Lettsom JC (1775)
On the improvement of medicine in London on the basis of public good. London: Phillips.

View

Millar J (1777)
Observations on the practice in the medical department of the Westminster General Dispensary. London, by order of the Governors.

View

Millar J (1779)
Observations on the management of the prevailing diseases particularly in the Army and Navy. London, for the author.

View

Dobson M (1779)
A medical commentary on fixed air. Chester: J. Monk.

View

Home F (1780)
Clinical experiments, histories and dissections. Edinburgh: Creech; London: Murray.

View

Clark J (1780)
Observations on fevers, especially of the continued type. London: T Cadell.

View

Black W (1782)
An historical sketch of medicine and surgery from their origin to the present time. London: J Johnson.

View

Lavoisier A-L de (1784)
Undated documents contained in: Mémoires de Lavoisier, Oeuvres, Tome III. Paris: Imprimerie Impériale, 1865. p 509.

View

Commission Royale. Bailly A (1784)
Rapport des commissaires chargés par le Roi, de l'examen du magnétisme animale [Report of the Comissioners required by the King to examine animal magnetism]. Imprimé par ordre du Roi. Paris: A Paris, de L'Imprimerie Royale.

View

Fowler T (1785)
Medical reports of the effects of tobacco in the cure of dropsies and dysuries.... London: J Johnson.

View

Fowler T (1786)
Medical reports of the effects of arsenic in the cure of agues, remitting fevers and periodic headachs. London: J Johnson, pp 105-107.

View

Percival T (1788)
Essays medical, philosophical and experimental Vol 1.4th ed. Warrington: Eyres, for London: Johnson.

View

Black W (1788)
A comparative view of the mortality of the human species at all ages. London: Dilly, pp 35-38.

View

Robertson R (1789)
Observations on jail, hospital, or ship fever. New ed. London: for the Author.

View

Black W (1789)
An arithmetical and medical analysis of the diseases and mortality of the human species. London: J Johnson.

View

Robertson R (1790)
Essay on fever. London: printed for the author.

View

Ferriar J (1792)
Medical histories and reflections. Vol 1. London: Cadell and Davies.

View

Clark J (1792)
Observations on the diseases which prevail in long voyages to hot countries. London: J Murray.

View

Rowley W (1793)
The causes of a great number of deaths amongst adults and children. 2nd edn. London: Newbery.

View

Fordyce G (1793)
An attempt to improve the evidence of medicine. Transactions of a Society for the Improvement of Medical and Chirurgical Knowledge.  London: J Johnson.

View

Hunter J (1794)
A treatise on the blood, inflammation and gun-shot wounds. London: G Nichol, p 531.

View

Ferriar J (1795)
Medical histories and reflections. Vol. 2. London: Cadell and Davies.

View

Fordyce G (1798)
A third dissertation on fever, Parts I & II. London: J Johnson.

View

Fordyce G (1803)
A fifth dissertation on fever. London: J Johnson.

View

Currie W (1804)
Medical reports of the effects of water: cold and warm as a remedy in fever and febrile diseases. Vol. 2. London: M’Creery & Cadell.

View

Blane G (1813)
Observations on the comparative prevalence, mortality, & treatment of different diseases.... Medico-chirurgical Transactions, Vol 4, p 89-141, London.

View

Guthrie GJ (1815)
A treatise on gun-shot wounds. London: Burgess and Hill.

View

Hutchinson AC (1817)
Some further observations on the subject of the proper period for amputating in gun-shot wounds. London: Callow, p16.

View

Marcet A (1819)
An essay on the chemical history and medical treatment of calculous disorders. London: Longman, Hurst, Rees, Orme and Brown.

View

Prout WM (1821)
An inquiry into the nature and treatment of gravel, calculus and other diseases connected with a deranged operation of the urinary organs. London: Baldwin, Cradock and Joy.

View

Richerand A (1825)
Histoire des progrès récens de la chirurgie [History of recent progress in surgery]. Paris: Béchet le Jeune, p 27.

View

Yelloly J (1829)
Remarks on the tendency to calculous diseases with observations on the nature of urinary concretions. Philosophical Transactions of the Royal Society 119: 55-81.

View

Hawkins FB (1829)
The elements of medical statistics. London: Longman, Rees, Orme, Brown & Green.

View

Magendie F (1829)
Formulaire pour la préparation et l'emploi de plusieurs médicaments. Paris, imprimerie de Plassan,1ère édition.

View

Todd TJ (1831)
The book of analysis or a new method of experience whereby the induction of the Novum Organon [of Bacon] is made easy of application to medicine, physiology… London, Murray.

View

Bostock J (1833)
History of medicine. In: Forbes et al. eds. The cyclopaedia of practical medicine. Vol 1. Sherwood et al.: London, pp i-lxxii (see p lxix).

View

Bigelow J (1835)
A discourse on self-limited diseases, delivered before the Massachusetts Medical Society at their annual meeting, May 27, 1835. Boston: Nathan Hale p 8-10.

View

Louis PCA (1835)
Recherches sur les effets de la saignée dans quelques maladies inflammatoires et sur l'action de l'émétique et des vésicatoires dans la pneumonie [Research on the effects of bloodletting in some inflammatory illnesses and on the action of emetics and blistering in pneumonia]. Paris: Librairie de l'Académie royale de médecine.

View

Louis PCA (1837)
The applicability of statistics to the practice of medicine. London Medical Gazette 20 :488-491.

View

Alcock R (1840)
Observations on injuries of joints and their treatment. Medico - chirurgical Transactions 23: 243-322.

View

Gavarret LDJ (1840)
Principes généraux de statistique médicale: ou développement des régles qui doivent présider à son emploi [General principles of medical statistics: or the development of rules that must govern their use]. Paris: Bechet jeune & Labé.

View

Alcock R (1840-41a)
Lectures on amputations and on the nature, progress and termination of the injuries for which it is required (Lecture 1 of 20). Lancet 1:105-111 and passim up to 2:849—858.

View

Alcock R (1840-41b)
Lectures on amputations and on the nature, progress and termination of the injuries for which it is required (Lecture 2 of 20). Lancet 1:217-220 and passim up to 2:849—858.

View

Bartlett E (1844)
An essay on the philosophy of medical science. Philadelphia: Lea and Blanchard.

View

Forbes J (1846)
Homoeopathy, allopathy and “young physic”. British and Foreign Medical Review 225-265.

View

Balfour TG (1854)
Quoted in West C. Lectures on the Diseases of Infancy and Childhood. London, Longman, Brown, Green and Longmans, p 600.

View

Treatment Committee of the Medical Council (1855)
Report on the results of the different methods of treatment pursued in epidemic cholera. [Metropolitan Report and Report on the Provinces throughout England and Scotland]. Report to the General Board of Health. London: Her Majesty’s Stationery Office.

View

Airy GB (1861)
On the algebraical and numerical theory of errors of observations and the combination of observations. Cambridge: MacMillan and Co.

View

Holmes OW (1861)
Currents and countercurrents in medical science with other addresses and essays. Boston: Ticknor and Fields, 1861.

View

Mill JS (1862)
A system of logic ratiocinative and inductive. 5th Edn,vol 1. London:Parker, Son and Bourn, pp418,431-3.

View

Béclard PA (1863)
Rapport général sur les prix décernés en 1862 [General report on the prizes awarded in 1862]. Mémoires de l’Académie Impériale de Médecine XXVI, Paris: Ballière, pp. xxii-xxxv.

View

Barclay AW (1864)
Medical errors: fallacies connected with the application of the inductive method of reasoning to the science of medicine. London: Churchill, p 55 and 71-73.

View

Sutton HG (1865)
Cases of rheumatic fever treated for the most part by mint water. Guy’s Hospital Reports 2:392-428.

View

Bernard C (1865)
Introduction à l'étude de la médicine expérimentale [Introduction to the study of experimental medicine]. Paris: Flammarion.

View

Bain A (1870)
Logic. London: Longmans, Green, Reader & Dyer p 362.

View

Wanscher O (1877)
Om Diphteritis og Croup - særligt med hensyn til Tracheostomien ved samme. [On diphtheria and croup - especially regarding tracheostomy in this condition]. Disputats [Thesis]. Jacob Lund: Kjøbenhavn, p 67-68.

View

Stuart W (1889)
A remarkable case of morphine addiction. BMJ 1:1051-52.

View

Andrew J (1891)
Harveian Oration. London: Adlard and Son. p 16-19.

View

Behring EA, Boer NN, Kossel H (1893)
Zur Behandlung diphtheriekranker Menschen mit Diphtherieheilserum [On the treatment of diphtheria patients with curative diphtheria serum]. Deutsche Medicinische Wochenschrift 17:389-39.

View

Ephraim A (1893)
Uber die Bedeutung de statistischen Methode für die Medicin [On the relevance of the statistical method for medicine]. Volkmann’s Sammlung Klinische Vortraege N.F. Innere Medicin 24:706-716. Leipzig: Breitkopf and Härtel.

View

Haffkine WM (1896)
Correspondence: Explanation of his inoculation report forms. Indian Medical Gazette 31:189-190.

View

Heiberg P (1897)
Studier over den statistiske undersøgelsesmetode som hjælpemiddel ved terapeutiske undersøgelser [Studies on the statistical study design as an aid in therapeutic trials]. Bibliotek for Læger 89:1-40.

View

Davenport CB (1899)
Statistical methods, with special reference to biological variation. New York: John Wiley & Sons.

View

Cotton FJ (1899)
The Present Status of the Antistreptococcic Serum. New England Journal of Medicine 140:105-109. DOI: 10.1056/NEJM189902021400501

View

Hulshoff-Pol MDJ (1902)
Katjang idjo, un nouveau medicament contre le béri-béri [Katjang idjo (mung beans), a new treatment for beri-beri]. Janus 7:524-581.

View

Pearson K (1904)
Report on certain enteric fever inoculation statistics. BMJ 3:1243-1246.

View

Rosenbach O (1905)
Die Diagnose als ätiologischer Factor [The diagnosis as a factor in aetiology]. Zeitschrift fur klinische Medicin 56:232-240.

View

Rivers WHR (1908)
The influence of alcohol and other drugs on fatigue. London: Edward Arnold.

View

Anonymous (1908)
Alcohol in the treatment of pneumonia and enteric fever. Lancet 157:442.

View

Alt K (1909)
Behandlungsversuche mit Arsenophenylglyzin bei Paralytikern [Treatment experiments with arsenophenylglycine in paralytics]. Muenchener Medizinische Wochenschrift 56:1457-1459.

View

Freeman J (1910)
Vaccine therapy. Proceedings of the Royal Society of Medicine 3:97-101.

View

Solis-Cohen M, Strickler A (1911)
The effect produced by some therapeutic measures on the different forms of leucocytes in pulmonary tuberculosis. New Enlgand Journal of Medicine 165:563-568.

View

Barnes HL (1912)
Report of 150 cases of pulmonary tuberculosis treated with tuberculin. JAMA 59:332-33.

View

Advisory Committee on Plague Investigations in India (1912)
The serum treatment of human plague. Journal of Hygiene. Plague Supplement II, LVI:326-39.

View

Wesselhoeft W (1915)
Hospital Efficiency from the Standpoint of Hospital Trustees. The New England Journal of Medicine 172:778. 10.1056/NEJM191505271722104

View

Council on Pharmacy and Chemistry (1917)
Biniodol. JAMA 68: 650-51.

View

Sollmann T (1917)
The crucial test of therapeutic evidence. JAMA 69:198-199.

View

Pearl R (1919)
A statistical discussion of the relative efficacy of different methods of treating pneumonia. Archives of Internal Medicine 24:398-403.

View

Bleuler E (1919)
Das Autistisch-Undisziplinierte Denken in der Medizin und Seine Überwindung [Autistic-undisciplined thinking in medicine and how to overcome it]. Berlin: Springer.

View

Mcguire LW, Redden WR (1919)
Treatment of Influenzal pneumonia by the use of convalescent human serum, Second report. JAMA 72:709-713. doi:10.1001/jama.1919.02610100017007

View

Acton HW (1920)
Researches on the treatment of benign tertian fever. Lancet 1:1257-1261.

View

McCall WA (1923)
How to experiment in education. New York: Macmillan.

View

Locke EA (1924)
The serologic treatment of lobar pneumonia. Boston Medical and Surgical Journal 190:196-203.

View

Greenwood M (1924)
Is the statistical method of any value in medical research? Lancet 2: 153-158.

View

Malaria Commission of the Health Organisation (1925)
Report on its tour of investigation in certain European countries in 1924. Geneva: League of Nations. C.H. 273.

View

Lewis S (1925)
Arrowsmith. New York: Collier.

View

Frost WH (1925)
Rendering account in public health. American Journal of Public Health 15:394-397.

View

Medical Research Council (1925)
Report of the committee upon cinchona derivatives and malaria. In: Clinical comparisons of quinine and quinidine. London: HMSO, pp 5-16.

View

Swellengrebel NH (1925)
A summary of the more important facts on adult anophelines and their larvae observed by us or brought to our notice duing our tour through eastern Europe and Italy (May-September 1924). pp183-190. In: Malaria Commission of the Health Organisation (1925). Report on its tour of investigation in certain European countries in 1924. Geneva: League of Nations. C.H. 273.

View

Bullowa JGM (1928)
Use of antipneumococcic refined serum in lobar pneumonia: data necessary for a comparison between cases treated with serum and cases not so treated, and the importance of a significant control series of cases. JAMA 90: 1354-1358.

View

Bullowa JGM (1928)
The control. Contribution to a symposium on the use of antipneumococcic refined serum in lobar pneumonia, 15 December 1927. Bulletin of the New York Academy of Sciences 4:339-343.

View

Park WH, Bullowa JGM, Rosenbluth NM (1928)
The treatment of lobar pneumonia with refined specific antibacterial serum. JAMA 91:1503-1508.

View

Ferry NS, Gordon EJ, Munro FW, Steele AH, Fisher LW (1928)
Clinical results with measles streptococcus toxin and antitoxin. JAMA 91:1277-1280.

View

Bullowa JGM (1929)
The serum treatment and its evaluation in lobar pneumonia. Bulletin of the New York Academy of Medicine 5:328-362.

View

Woods HM, Russell WT (1931)
An introduction to medical statistics. London: Staples Press.

View

Ellison JB (1932)
Intensive vitamin therapy in measles. BMJ 2:708-711.

View

Medical Research Council Therapeutic Trials Committee (1934)
The serum treatment of lobar pneumonia. BMJ 1:241-245.

View

Greenwood M (1934)
Epidemics and crowd-diseases. Oxford: Oxford University Press.

View

Bentley PJ (1936)
Artificial pneumothorax: experience of the London County Council. Medical Research Council. London: Her Majesty's Stationary Office.

View

Sutliff WD (1936)
Adequate tests of curative therapy in man. Annals of Internal Medicine 1936-1937;10:89-97.

View

Gilliam AG, Onstott RH (1936)
Results of field studies with poliomyelitis vaccine. American Journal of Public Health 26:113-118.

View

Bullowa JGM (1937)
Serum therapy. In: Bullowa JGM. The management of the pneumonias. New York: Oxford University Press, pp 283-298.

View

Editorial (1937)
Mathematics and medicine. Lancet 1:31.

View

Hill AB (1937)
Artificial pneumothorax on statistical trial. Lancet 229: 535-536.

View

Hill AB (1937)
Principles of medical statistics. I. The aim of the statistical method; and General summary and conclusions. Lancet 1:41-43 and 883-885.

View

Parrot A, Catanei A, Ambialet R, Clastrier J (1937)
Comparative experiments in mass prophylaxis of malaria by means of quinine and synthetic drugs (quinacrine and praequine). Bulletin of the Health Organization of the League of Nations 6:685-765.

View

Hill AB (1937)
Principles of medical statistics. London: Lancet.

View

Theobald GW (1937)
Effect of calcium and vitamin A and D on incidence of pregnancy toxaemia. Lancet 2:1397-1399.

View

Riseman JEF, Brown MG (1937)
Medicinal treatment of angina pectoris. Archives of Internal Medicine 60:100-118.

View

Mainland D (1938)
The treatment of clinical and laboratory data: an introduction to statistical ideas and methods for medical and dental workers. Edinburgh: Oliver and Boyd.

View

Aykroyd WR, Krishnan RSBG (1938)
Effect of calcium lactate on children in a nursery school. Lancet 2:153-155.

View

Kendrick P, Eldering G (1939)
A study in active immunization against pertussis. American Journal of Hygiene 29 Sec. B:133-153.

View

Dahlberg G (1940)
Statistical methods for medical and biological students. London: George Allen & Unwin.

View

Lindquist EF (1940)
Statistical analysis in educational research. Boston: Houghton Mifflin.

View

Gaddum JH (1940)
Pharmacology. London: Oxford University Press 378-383.

View

Price MR (1940)
Effects of a supplement of vitamin B (adsorbate) on the growth of infants. BMJ 2:80-82.

View

Bell JA (1941)
Pertussis prophylaxis with two doses of alum-precipitated vaccine. Public Health Reports 56:1535-1546.

View

Hinshaw HC, Feldman WH (1944)
Evaluation of therapeutic agents in clinical tuberculosis. American Review in Tuberculosis 50:202-213.

View

Van Winkle W, Herwick RF, Calvery HO, Smith A (1944)
Laboratory and clinical appraisal on new drugs. Report of the Council on Pharmacy and Chemistry. JAMA 126:958-961.

View

Mackenna RMB, Cooper-Willis ES (1945)
Impetigo contagiosa in the army, treated with microcrystalline sulphathiazole. Lancet 2:357-358.

View

Bell JA (1948)
The epidemiological principles and procedures involved in a study of the prophylactic value of an alum-precipated mixture of diphtheria toxoid and pertussis vaccine. Thesis submitted to the School of Hygiene and Public Health of the Johns Hopkins University in conformity with the requirements for the Degree of Doctor of Public Health.

View

Bell JA (1948)
Pertussis immunization use of two doses of an alum-precipitated mixture of diphtheria toxoid and pertussis vaccine. JAMA 137:1276-1281.

View

Bell JA (1948)
Diphtheria immunization use of an alum-precipitated mixture of pertussis vaccine and diphtheria toxoid. JAMA 137:1009-1016.

View

Mainland D (1948)
Statistical methods in medical research. Canadian Journal of Research E, 26:1-166.

View

Marshall EK (1949)
Clinical therapeutic trial of a new drug. Bulletin of the Johns Hopkins Hospital 85:221-230.

View

Reid DD (1950)
Statistics in clinical research. Annals of the New York Academy of Sciences 52:931-934.

View

Editorial (1950)
Are statistics necessary? JAMA 143:1260-1261.

View

Rinzler SH, Bakst H, Benjamin Z, Bobb AL, Travell J (1950)
Failure of alpha tocopherol to influence chest pain in patients with heart disease. Circulation 1:288-293.

View

Baker C, Brock RC, Campbell M (1950)
Valvulotomy for mitral stenosis; report of six successful cases. BMJ 1:1283–1293.

View

Hill AB (1951)
The clinical trial. British Medical Bulletin 7:278-282.

View

Daniels M (1951)
Clinical evaluation of chemotherapy in tuberculosis. British Medical Bulletin 7:320-326.

View

Ross OB (1951)
The use of controls in medical research. JAMA 145:72-75.

View

Bernstein L, Weatherall M (1952)
Statistics for medical and other biological students. London: E & S Livingstone.

View

Hill AB (1952)
The clinical trial. New England Journal of Medicine 247:113-119.

View

Bross I (1952)
Sequential medical plans. Biometrics 8:188-205.

View

Baker C, Brock RC, Campbell M, Wood P (1952)
Valvulotomy for mitral stenosis; a further report on 100 cases. BMJ 1:1043–1055.

View

Mainland D (1952)
Intercurrent Events. In: Elementary Medical Statistics: the principles of quantitative medicine. London: WB Saunders Company, p 109. [Facimile copy printed and bound in India. Pranava Books. 2- LB100151138852 -301 -4 sa.]

View

Rinzler SH, Travell J, Bakst H, Benjamin ZH, Rosenthal RL, Rosenfeld S, Hirsch BB (1953)
Effect of heparin in effort angina. American Journal of Medicine 14:438-447.

View

Hamilton M, Wilson GM, Armitage P, Boyd JT (1953)
The treatment of intermittent claudication with Vitamin E. Lancet 1: 367-370.

View

Kilpatrick GS, Oldham PD (1954)
Calcium chloride and adrenaline as bronchial dilators compared by sequential analysis. BMJ 2:1388-1391.

View

Hogben L (1954)
The assessment of remedies. Medical Press 232:331-338.

View

Miall WE, Oldham PD, Cochrane AL (1954)
The treatment of complicated pneumoconiosis with isoniazid. British Journal of Industrial Medicine 11:186-191.

View

Gaddum JH (1954)
Clinical pharmacology. Proceedings of the Royal Society of Medicine 47:195-204.

View

Herdan G (1955)
Statistics of Therapeutic Trials. Amsterdam: Elsevier.

View

Lasagna L (1955)
The controlled clinical trial: theory and practice. Journal of Chronic Diseases 1:353-367.

View

Newton DRL, Tanner JM (1956)
N-acetyl-para-aminophenol as an analgesic. A controlled clinical trial using the method of sequential analysis. BMJ 2:1096-9.

View

Tebrock HE, Arminio JJ, Johnston JH (1956)
Usefulness of bioflavinoids and ascorbic acid in treatment of common cold. JAMA 162:1227-1233.

View

Snell ES, Armitage P (1957)
Clinical comparison of diamorphine and pholcodine as cough suppressants by a new method of sequential analysis. Lancet 1:860-862

View

Bjerkelund CJ (1957)
The effect of long-term treatment with dicoumarol in myocardial infarction. A controlled clinical study. Acta Med Scand Suppl 330:1-212.

View

Greiner T, Bross I, Gold H (1957)
A method for evaluation of laxative habits in human subjects. Journal of Chronic Diseases 6:244-255.

View

Sutherland I (1958)
Statistical aspects of clinical trials. In: Dodds C, ed. Report of a Symposium on Clinical Trials held at The Royal Society of Medicine, London, 25 April, p 53, pp 50-55.

View

Watkinson G (1958)
Treatment of ulcerative colitis with topical hydrocortisone hemisuccinate sodium. A controlled trial employing restricted sequential analysis. BMJ 2:1077-82.

View

Cox DR (1958)
Planning of experiments. London: Wiley.

View

Symposium on Clinical Trials RSM (1958)
Report of a meeting held at the Royal Society of Medicine, London on 25th April 1958.

View

Witts LJ (1959)
Medical surveys and clinical trials: some methods and applications of group research in medicine. Oxford: Oxford University Press.

View

Oldham PD (1959)
Clinical and field trials. Acta Medica Hungarica 14:313-326.

View

Doll R (1959)
Practical problems of drug trials in clinical practice. Lawrence DR, ed. Quantitative methods in human pharmacology and therapeutics. Oxford: Pergamon Press, pp. 213-221.

View

Waife SO, Shapiro AP (1959)
The clinical evaluation of new drugs. New York: Hoeber-Harper.

View

Bull JP (1959)
The historical development of clinical therapeutic trials. Journal of Chronic Diseases 10:218-248.

View

Robertson JD, Armitage P (1959)
Report of a clinical trial to compare two hypotensive agents. Anaesthesia 14:53-64.

View

Knowelden J (1959)
Prophylactic trials. In: Witts LJ ed. Medical Surveys and Clinical Trials. London: Oxford University Press. pp 118-133.

View

Laurence DR, ed. (1959)
Quantitative Methods in Human Pharmacology and Therapeutics. London: Pergamon Press.

View

Lasagna L, Meier P (1959)
Experimental Design and Statistical Problems. In: Waife SO, Shapiro AP, eds. The Clinical Evaluation of New Drugs. New York: Hoeber. pp 37-60.

View

Knowelden J (1960)
The analysis and presentation of results. In: Hill AB, ed. Controlled Clinical Trials. In: Hill AB, ed. Controlled Clinical Trials. Oxford: Blackwell Scientific Publications, 155-159.

View

Bywaters E (1960)
Rheumatoid arthritis. Treatment and illustrative answers. In: Hill AB ed. Controlled Clinical Trials. Oxford: Blackwell Scientific Publications, pp 75-83.

View

Armitage P (1960)
Sequential medical trials. Oxford: Blackwell.

View

Schwartz D, Flamant R, Lellouch J, Rouquette C (1960)
Les essais thérapeutiques cliniques [Controlled clinical trials]. Paris: Masson.

View

Hill AB (1960)
Controlled clinical trials. Oxford: Blackwell Scientific Publications.

View

Zubrod CG, Schneiderman M, Frei E, Brindley C, Gold GL, Shnider B, Oviedo R, Gorman J, Jones R, Jonsson U, Colsky J, Chalmers T, Ferguson B, Dederick M, Holland J, Selawry O, Regelson W, Lasagna L, Owens AH (1960)
Appraisal of methods for the study of chemotherapy in man: Comparative therapeutic trial of nitrogen mustard and thiophosphoramide. Journal of Chronic Diseases 11:7-33.

View

Mainland D (1960)
The use and misuse of statistics in medical publications. Clinical Pharmacology and Therapeutics 1:411-22.

View

Cochran WG (1961)
Designing clinical trials. In: Forster FM, ed. Evaluation of drug therapy. University of Wisconsin Press, pp 71-77.

View

Truelove SC, Watkinson G, Draper G (1962)
Comparison of corticosteroid and sulphasalazine therapy in ulcerative colitis. BMJ 2:1708-1711.

View

Cohen J (1962)
The statistical power of abnormal-social psychological research: a review. Journal of Abnormal Social Psychology 65:145-153.

View

Hill AB (1962)
Alfred Watson Memorial Lecture: The Statistician in Medicine. Journal of the Institute of Actuaries 88:178-191. doi:10.1017/S0020268100014980

View

Mainland D (1963)
Elementary medical statistics: 2nd edn. Philadelphia: WB Saunders Co.

View

Campbell DT, Stanley JC (1963)
Experimental and quasi-experimental designs for research. Chicago: Rand McNally & Company.

View

Percy JS, Stephenson P, Thompson M (1964)
Indomethacin in the treatment of rheumatic diseases. Annals of Rheumatic Diseases 28:157-162.

View

Schneiderman MA (1966)
Therapeutic trials in cancer. Working paper prepared for WHO Expert Committee on Cancer Treatment, Geneva, Switzerland, 9-15 March 1965. WHO/CANC/66.66.

View

Pollock TM, Bell JA, Hill AB, Cockburn WC, Cvjetanović B, Evans DG, Kostrzewski J, Schofield FD (1966)
Trials of Prophylactic agents for the control of communicable diseases: a guide to their organization and evaluation‎. Geneva: World Health Organization.

View

Schwartz D, Lellouch J (1967)
Explanatory and pragmatic attitudes in therapeutic trials. Journal of Chronic Diseases 20:637-48.

View

Chalmers TC (1968)
When should randomisation begin? Lancet 1:858.

View

Schwartz D, Flamant R, Lellouch J (1970)
L’essai thérapeutique chez l‘homme. Paris: Flammarion.

View

Cornfield J (1971)
The University Group Diabetes Program: a further statistical analysis of the mortality findings. JAMA 217:1676-87.

View

Cochrane AL (1972)
Effectiveness and Efficiency: random reflections on health services. London: Nuffield Provincial Hospitals Trust.

View

Chalmers TC (1975)
Randomization of the first patient. Medical Clinics of North America 59:1035-1038.

View

Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, Mantel N, McPherson K, Peto J, Smith PG (1976)
Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design. British Journal of Cancer 34:585-6.

View

Cornfield J (1976)
Recent methodological contributions to clinical trials. American Journal of Epidemiology 104:408-421.

View

Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, Mantel N, McPherson K, Peto J, Smith PG (1977)
Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. British Journal of Cancer 35:1-39. PMID 831755.

View

Pocock SJ (1977)
Randomised clinical trials. BMJ 1:1661.

View

Bunker JP, Barnes BA, Mosteller F (1977)
Costs, risks and benefits of surgery. Oxford: Oxford University Press.

View

Freiman JA, Chalmers TC, Smith H, Kuebler RR (1978)
The importance of beta, the type II error and sample size in the design and interpretation of the randomized control trial. Survey of 71 "negative" trials. New England Journal of Medicine 299:690-94.

View

Farquhar JW (1978)
The community-based model of life style intervention trials. American Journal of Epidemiology 108:103-111.

View

Peto R (1978)
Clinical trial methodology. Biomedicine 28 (special issue):24-36.

View

Sackett DL (1979)
Bias in analytic research. Journal of Chronic Diseases 32:51-63.

View

Chalmers TC, Smith JH, Blackburn B, Silverman B, Schroeder B, Reitman D, Ambroz A (1981)
A method for assessing the quality of a randomized control trial. Controlled Clinical Trials 2: 31-49.

View

Pocock SJ (1983)
Clinical trials: a practical approach. Chichester: John Wiley.

View

Bulpitt CJ (1984)
Randomised controlled clinical trials. The Hague: Martinus Nijhoff.

View

Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI) (1986)
Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1: 397-402.

View

Peto J, Eden OB, Lilleyman J, Richards S (1986)
Improvement in treatments for children with acute lymphoblastic leukaemia: The Medical Research Council UKALL Trials, 1972-84. Lancet 1:408-411.

View

Jenicek M (1987)
Méta-analyse en médecine. Évaluation et synthèse de l’information clinique et épidémiologique. [Meta-analysis in medicine: evaluation and synthesis of clinical and epidemiological information] St.Hyacinthe and Paris: EDISEM and Maloine Éditeurs.

View

Machin D, Campbell MJ (1987)
Statistical Tables for the Design of Clinical Trials. Oxford: Blackwell scientific publications.

View

ISIS-2 (second International Study of Infarct Survival) Collaborative Group (1988)
Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17 187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 332:349–360.

View

Chalmers TC (1988)
Data analysis for clinical medicine: the quantitative approach to patient care in gastroenterology. Rome: International University Press.

View

O’Rourke K, Detsky AS (1989)
Meta-analysis in medical research: strong encouragement for higher quality in individual research efforts. Journal of Clinical Epidemiology 42:1021-24.

View

Pocock SJ, Hughes MD (1989)
Practical problems in interim analyses, with particular regard to estimation. Control Clinical Trials10 (4 Suppl):209S-221S.

View

Jenicek M (1989)
Meta-analysis in medicine: where we are and where we want to go. Journal of Clinical Epidemiology 42:35-44.

View

Donner A, Brown KS, Brasher P (1990)
A methodological review of non-therapeutic intervention trials employing cluster randomization, 1979-1989. International Journal of Epidemiology 19:795-800.

View

Hill AB, Hill ID (1991)
Differential exclusions. In: Bradford Hill’s Principles of Medical Statistics. 12th edition. London: Edward Arnold. pp 226-228.

View

Simpson JM, Klar N, Donner A (1995)
Accounting for cluster randomization: a review of primary prevention trials, 1990 through 1993. American Journal of Public Health 85:1378-1383.

View

Schulz KF, Chalmers I, Altman DG, Grimes DA, Doré CJ (1995)
The methodologic quality of randomization as assessed from reports of trials in specialist and general medical journals. Online Journal of Current Clinical Trials 4:197.

View

Murray DM (1998)
Design and Analysis of Group Randomized Trials. New York: Oxford University Press Inc.

View

Hollis S, Campbell F (1999)
What is meant by intention-to-treat analysis? Survey of published randomised controlled trials. BMJ 319:670-674.

View

Ruiz-Canela M, Martinez-Gonzalez MA, de Irala-Estevez J (2000)
Intention-to-treat analysis is related to methodological quality. BMJ 320:107-108.

View

Stangl D, Berry DA (2000)
Meta-Analysis in Medicine and Health Policy. New York: Marcel Dekker, Inc.

View

Sutton AJ, Abrams KR, Jones DR, Sheldon T, Song F (2000)
Methods for Meta-Analysis in Medical Research. Chichester: Wiley.

View

Wagner AK, Soumerai SB, Zhang F, Ross-Degnan D (2002)
Segmented regression analysis of interrupted time series studies in medication use research. Journal of Clinical Pharmacy and Therapeutics 27:299–309.

View

Jones B, Kenward MG (2003)
Design and Analysis of Cross-Over-Trials (2nd Ed). London and USA: Chapman and Hall.

View

Atkins D, Eccles M, Flottorp S, Guyatt GH, Henry D, Hill S, Liberati A, O'Connell D, Oxman AD, Phillips B, Schünemann H, Edejer TT, Vist GE, Williams JW and The GRADE Working Group (2004)
Systems for grading the quality of evidence and the strength of recommendations I: Critical appraisal of existing approaches The GRADE Working Group. BMC Health Services Research 2004 4:38 doi.org/10.1186/1472-6963-4-38.

View

Montori VM, Devereaux PJ, Adhikari NK, Burns KE, Eggert CH, Briel M, Lacchetti C, Leung TW, Darling E, Bryant DM, Bucher HC, Schunemann HJ, Meade MO, Cook DJ, Erwin PJ, Sood A, Sood R, Lo B, Thompson CA, Zhou Q, Mills E, Guyatt GH (2005)
Randomized trials stopped early for benefit: a systematic review. JAMA 294:2203-2209.

View

Perel P, Roberts I, Sena E, Wheble P, Briscoe C, Sandercock S, Macleod M,  Mignini LE, Jayaram P, Khan KS (2007)
Comparison of treatment effects between animal experiments and clinical trials: systematic review. BMJ 334:197-200.

View

Glasziou P, Chalmers I, Rawlins M, McCulloch P (2007)
When are randomised trials unnecessary? Picking signal from noise. BMJ 334: 349-351.

View

Trotta F, Apolone G, Garattini S, Tafuri G (2008)
Stopping a trial early in oncology: for patients or for industry? Annals of Oncology Feb 29; doi:10.1093/annonc/mdn042.

View

Djulbegovic B, Kumar A, Soares HP, Hozo I, Bepler G, Clarke M, Bennett CL (2008)
Treatment success in cancer: new cancer treatment successes identified in phase 3 randomized controlled trials conducted by the national cancer institute-sponsored cooperative oncology groups, 1955 to 2006. Archives of Internal Medicine. 168:632-42.

View

Kramer MS, Martin RM, Sterne JA, Shapiro S, Mourad D, Platt RW (2009)
The double jeopardy of clustered measurement and cluster randomisation. BMJ 339:503-505.

View

Bassler D, Briel M, Montori VM, Lane M, Glasziou P, Zhou Q, Heels-Ansdell D, Walter SD, Guyatt GH; STOPIT-2 Study Group (2010)
Stopping randomized trials early for benefit and estimation of treatment effects: systematic review and meta-regression analysis. JAMA. 303:1180-7.

View

Montedori A, Cherubini A, Bonacini MI, Casazza G, Luchetta ML, Duca P, Cozzolino F, Abraha I (2011)
Modified versus standard intention-to-treat reporting: Are there differences in methodological quality, sponsorship, and findings in randomised trials? A cross-sectional study. Trials 12:58.

View

Clarke M, Loudon K (2011)
Effects on patients of their healthcare practitioner's or institution's participation in clinical trials: a systematic review. Trials 12:16.

View

Fretheim A, Zhang F, Ross-Degnan D, Oxman AD, Cheyne H, Foy R, Goodacre S, Herrin J, Kerse N, McKinlay RJ, Wright A, Soumerai SB (2014)
A reanalysis of cluster randomized trials showed interrupted time-series studies were valuable in health system evaluation. Journal of Clinical Epidemiology 68:324-33.

View

Sackett DL (2015)
Sackett DL. Interview in 2014 and 2015. Brian Haynes, ed. McMaster University.

View

Abraha I, Cherubini A, Cozzolino F, De Florio R, Luchetta ML, Rimland JM, Folletti I, Marchesi M, Germani A, Orso M, Eusebi P, Montedori A (2015)
Deviation from intention to treat analysis in randomised trials and treatment effect estimates: meta-epidemiological study. BMJ 2015;350:h2445.

View

Page MJ, Higgins JPT, Clayton G, Sterne JAC, Hróbjartsson A, Savović J (2016)
Empirical Evidence of Study Design Biases in Randomized Trials: Systematic Review of Meta-Epidemiological Studies. PLOS ONE 11(7):e0159267.

View

Chalmers I (2017)
The evolution of fair tests of treatments over two millennia: a 23 minute audio commentary. Edited by Hamish Chalmers, using unbroadcast recordings made by Freakonomics Radio, with permission.

View

Bradley SH, DeVito NJ, Lloyd KE, Richards GC, Rombey T, Wayant C, Gill PJ (2020)
Reducing bias and improving transparency in medical research: a critical overview of the problems, progress and suggested next steps. Journal of the Royal Society of Medicine 113:433-443.

View

Pan H, Peto R, Karim QA, Alejandria M, Henao-Restrepo AM, García CH, Kieny MP, Malekzadeh R, Murthy S, Preziosi MP, Reddy S, Periago MR, Sathiyamoorthy V, Røttingen JA, Swaminathan S, WHO Solidarity trial consortium (2020)
Repurposed antiviral drugs for COVID-19 –interim WHO SOLIDARITY trial results. MedRxiv. doi: https://doi.org/10.1101/2020.10.15.20209817

View

RECOVERY Trial Team (2020)
Randomized Evaluation of COVID019 Therapy (RECOVERY). RECOVERY Central Coordinating Office, Oxford. www.recoverytrial.net

View

Horby P, Mafham M, Linsell L, Bell JL, Staplin N, Emberson JR, Wiselka M, Ustianowski A, Elmahi E, Prudon B, Whitehouse A, Felton T, Williams J, Faccenda J, Underwood J, Baillie JK, Chappell L, Faust SN, Jaki T, Jeffery K, Lim WS, Montgomery A, Rowan K, Tarning J, Watson JA, White NJ, Juszczak E, Haynes R, Landray MJ (2020)
Effect of Hydroxychloroquine in Hospitalized Patients with COVID-19: Preliminary results from a multi-centre, randomized, controlled trial. doi: https://doi.org/10.1101/2020.07.15.20151852

View

Horby P, Lim WS, Emberson J, Mafham M, Bell J, Linsell L, Staplin N, Brightling C, Ustianowski A, Elmahi E, Prudon B, Green C, Felton T, Chadwick D, Rege K, Fegan C, Chappell LC, Faust SN, Jaki T, Jeffrey K, Montgomery A, Rowan K, Juszcak E, Baillie JK, Haynes R, Landray MJ, on behalf of the RECOVERY Collaborative Group (2020)
Effect of Dexamethasone in Hospitalized Patients with COVID-19: Preliminary Report. medRχiv. Doi: https://doi.org/10.1101/2020.06.22.20137273

View

Show


Bull JP (1951).
A study of the history and principles of clinical therapeutic trials. MD Thesis, University of Cambridge. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Pazzini A (1958).
Angelo Celli (1857-1914). JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Marks HM† (1987).
Ideas as reforms: Therapeutic Experiments and Medical Practice, 1900-1980. Philosophy Thesis, Massachusetts institute of technology. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Cox-Maksimov D (1997).
The Making of the Clinical Trial in Britain, 1910-1945: Expertise, the State and the Public. Philosophy Thesis, University of Cambridge. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Silverman WA†, Chalmers I (2002).
Casting and drawing lots: a time-honoured way of dealing with uncertainty and for ensuring fairness. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Armitage P† (2003).
Some recollections of the early years of the Medical Research Council (MRC) Statistical Research Unit. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Stoll S (2004).
Paul Martini’s Methodology of therapeutic investigation. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Williams KJ (2005).
British Pharmaceutical Industry, Synthetic Drug Manufacture and the Clinical Testing of Novel Drugs, 1895-1939. Philosophy Thesis, University of Manchester. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Crofton J† (2006).
John Crofton (1912-2009). JLL Bulletin: Commentaries on the history of treatment evaluation.

View

McPherson K, Bunker JP (2006).
Costs, risks and benefits of surgery: a milestone in the development of health services research. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Neuhauser D, Diaz M (2006).
Jesse GM Bullowa (1879-1943). JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Petrosino A (2006).
Charles Frederick [Fred] Mosteller (1916-2006). JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Tansey EM (2006).
Philip Montagu D’Arcy Hart (1900-2006). JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Grimes DA (2007).
Discovering the need for randomized controlled trials in obstetrics: a personal odyssey. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Morabia A (2007).
Claude Bernard, statistics, and comparative trials. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Neuhauser D, Diaz M (2007).
Russell LaFayette Cecil (1881-1965). JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Bracken MB (2008).
Why animal studies are often poor predictors of human reactions to exposure. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Erill S (2008).
Louis Lasagna (1923-2003). JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Jick H (2008).
Learning how to control biases in studies to identify adverse effects of drugs: a brief personal history. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Bryder L (2010).
The Medical Research Council and clinical trial methodologies before the 1940s: the failure to develop a ‘scientific’ approach. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Gluud C (2010).
Danish contributions to the evaluation of serum therapy for diphtheria in the 1890s. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Stoll S (2010).
Paul Franz Xavier Martini (1889-1964). JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Tröhler U (2010).
Johann Friedrich de Quervain (1868-1940). Swiss surgical innovator. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Bryder L (2014).
The Medical Research Council and treatments for tuberculosis before streptomycin. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Bird SM (2014).
The 1959 meeting in Vienna on controlled clinical trials – a methodological landmark. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Toth B (2015).
Why the MRC Therapeutic Trials Committee didn’t introduce controlled clinical trials. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Burton MJ (2015).
Astley Cooper’s dramatically effective treatment of deafness. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Donaldson IML (2016).
Antoine de Lavoisier’s role in designing a single-blind trial to assess whether ‘Animal Magnetism’ exists. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Gachelin G, Garner P, Ferroni E, Tröhler U, Chalmers I (2016).
Evaluating Cinchona bark and quinine for treating and preventing malaria. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Donaldson IML (2016).
van Helmont’s proposal for a randomised comparison of treating fevers with or without bloodletting and purging. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Mirza RD, Punja S, Vohra S, Guyatt G (2017).
The history and development of N of 1 trials. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Altman DG† (2017).
Donald Mainland: anatomist, educator, thinker, medical statistician, trialist, rheumatologist. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Bailey R, Howick J (2018).
Did John Stuart Mill influence the design of controlled clinical trials? JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Toth B (2018).
Pioneering controlled trials of treatments for erysipelas and pneumonia in Glasgow, 1936-47. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Tognoni G, Franzosi MG, Garattini S (2018).
Embedding patient- and public health-oriented research in a national health service: the GISSI experience. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Bird A (2018).
James Jurin and the avoidance of bias in collecting and assessing evidence on the effects of variolation. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Marson Smith P, Colquhoun D, Chalmers I (2019).
John Henry Gaddum’s 1940 guidance on controlled clinical trials JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Johnson A† (2019).
Textbooks and other publications on controlled clinical trials, 1948 to 1983. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Jefferson T (2019).
Sponsorship bias in clinical trials – growing menace or dawning realisation? JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Tröhler U (2020)
Probabilistic thinking and the evaluation of therapies, 1700-1900. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Welsh BC, Podolsky SH, Zane SN (2020).
Between medicine and criminology: Richard Cabot’s contribution to the design of experimental evaluations of social interventions in the late 1930s. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Ritskes-Hoitinga M, Pound P (2022).
The role of systematic reviews in identifying the limitations of preclinical animal research, 2000 – 2022. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Nylenna, M (2023).
Paul Owren, Christopher Bjerkelund and the dawn of controlled trials in Norway. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Glasziou P, Matthews R, Boutron I, Chalmers I, Armitage P† (2023)
The differences and overlaps between ‘explanatory’ and ‘pragmatic’ controlled trials: a historical perspective. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Nothing found, please try resetting your search filters